UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Chimera Investment Co. (NYSE:CIM – Free Report) by 67.3% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 147,621 shares of the real estate investment trust’s stock after acquiring an additional 59,380 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.18% of Chimera Investment worth $2,337,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in CIM. Quarry LP lifted its stake in Chimera Investment by 1,188.3% in the second quarter. Quarry LP now owns 2,203 shares of the real estate investment trust’s stock worth $28,000 after purchasing an additional 2,032 shares during the last quarter. Prospera Private Wealth LLC bought a new stake in shares of Chimera Investment in the 3rd quarter valued at about $65,000. Simplify Asset Management Inc. purchased a new stake in Chimera Investment during the 3rd quarter valued at about $158,000. Cetera Advisors LLC bought a new position in Chimera Investment during the 1st quarter worth approximately $63,000. Finally, Moloney Securities Asset Management LLC increased its stake in Chimera Investment by 14.1% in the 3rd quarter. Moloney Securities Asset Management LLC now owns 13,913 shares of the real estate investment trust’s stock worth $220,000 after purchasing an additional 1,719 shares during the period. Hedge funds and other institutional investors own 48.44% of the company’s stock.
Insider Activity at Chimera Investment
In related news, CIO Jack Lee Macdowell, Jr. purchased 50,000 shares of the business’s stock in a transaction that occurred on Friday, December 6th. The shares were acquired at an average price of $14.70 per share, for a total transaction of $735,000.00. Following the completion of the acquisition, the executive now directly owns 50,000 shares in the company, valued at approximately $735,000. The trade was a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.91% of the stock is owned by company insiders.
Chimera Investment Stock Performance
Chimera Investment (NYSE:CIM – Get Free Report) last announced its quarterly earnings results on Wednesday, November 6th. The real estate investment trust reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.01). Chimera Investment had a net margin of 46.48% and a return on equity of 7.69%. The firm had revenue of $195.30 million for the quarter, compared to analysts’ expectations of $69.90 million. During the same period in the previous year, the company earned $0.39 EPS. Equities research analysts predict that Chimera Investment Co. will post 1.47 earnings per share for the current year.
Chimera Investment Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Monday, September 30th were paid a $0.37 dividend. The ex-dividend date of this dividend was Monday, September 30th. This is a boost from Chimera Investment’s previous quarterly dividend of $0.35. This represents a $1.48 annualized dividend and a dividend yield of 9.81%. Chimera Investment’s dividend payout ratio (DPR) is presently 44.85%.
Chimera Investment Company Profile
Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.
Featured Stories
- Five stocks we like better than Chimera Investment
- How to Read Stock Charts for Beginners
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- EV Stocks and How to Profit from Them
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding CIM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chimera Investment Co. (NYSE:CIM – Free Report).
Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.